Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
53 hedge funds and large institutions have $26.5M invested in Avid Bioservices, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 22 closing their positions.
244% more call options, than puts
Call options by funds: $213K | Put options by funds: $62K
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
8% less capital invested
Capital invested by funds: $28.8M → $26.5M (-$2.28M)
12% less funds holding
Funds holding: 60 → 53 (-7)
23% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 22
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSP
Tappan Street Partners
Chicago,
Illinois
|
+$4.56M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.83M |
| 3 |
BP
Bandera Partners
New York
|
+$1.32M |
| 4 |
FM
Fondren Management
Houston,
Texas
|
+$770K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$754K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.97M |
| 2 |
QI
QS Investors
New York
|
-$306K |
| 3 |
BlackRock
New York
|
-$168K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$114K |
| 5 |
Squarepoint
New York
|
-$89K |
CDMO Hedge Fund Activity: Q3 2017 in Review
53 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2017, worth a combined $26.5M — down 7.9% from $28.8M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of CDMO and 17 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 22 added.
The largest buyer was Tappan Street Partners, adding an estimated $4.56M. The largest seller was Kennedy Capital Management, cutting an estimated $4.97M.
- 53 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2017, down from 60 in Q2 2017.
- Funds reported $26.5M of Avid Bioservices, Inc. Common Stock stock for Q3 2017, down 7.9% quarter-over-quarter.
- 17 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2017 and 22 closed out, a net change of -5 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2017 was Tappan Street Partners, an estimated $4.56M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2017 was Kennedy Capital Management, an estimated $4.97M sold.
Based on aggregated 13F filings for Q3 2017.